Acadia Healthcare (NASDAQ:ACHC) Earns Outperform Rating from Royal Bank of Canada

Royal Bank of Canada reissued their outperform rating on shares of Acadia Healthcare (NASDAQ:ACHC) in a research note issued to investors on Friday morning, Benzinga reports. Royal Bank of Canada currently has a $94.00 price objective on the stock.

ACHC has been the subject of several other research reports. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a hold rating in a research note on Friday, August 2nd. Cantor Fitzgerald reaffirmed a neutral rating and set a $90.00 price target on shares of Acadia Healthcare in a research report on Monday, August 19th. Finally, Barclays lowered their price objective on Acadia Healthcare from $89.00 to $83.00 and set an overweight rating for the company in a research report on Thursday, August 1st. One analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Acadia Healthcare currently has an average rating of Moderate Buy and a consensus target price of $87.44.

Acadia Healthcare Price Performance

NASDAQ ACHC opened at $76.40 on Friday. The company has a market cap of $7.09 billion, a PE ratio of -545.71, a P/E/G ratio of 2.22 and a beta of 1.30. Acadia Healthcare has a 52-week low of $62.04 and a 52-week high of $87.77. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18. The firm’s 50 day moving average price is $73.53 and its 200-day moving average price is $71.88.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The business had revenue of $796.00 million for the quarter, compared to the consensus estimate of $784.38 million. During the same period last year, the business posted $0.92 EPS. The business’s revenue was up 8.8% compared to the same quarter last year. Sell-side analysts forecast that Acadia Healthcare will post 3.51 EPS for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Large investors have recently bought and sold shares of the company. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Acadia Healthcare during the 2nd quarter valued at approximately $59,000. Sanctuary Advisors LLC purchased a new position in Acadia Healthcare during the second quarter worth approximately $417,000. Clearbridge Investments LLC raised its position in Acadia Healthcare by 36.0% during the second quarter. Clearbridge Investments LLC now owns 275,474 shares of the company’s stock worth $18,605,000 after acquiring an additional 72,924 shares during the period. Teachers Retirement System of The State of Kentucky grew its position in shares of Acadia Healthcare by 75.6% in the second quarter. Teachers Retirement System of The State of Kentucky now owns 52,168 shares of the company’s stock valued at $3,523,000 after purchasing an additional 22,465 shares during the period. Finally, Clearline Capital LP purchased a new stake in shares of Acadia Healthcare during the second quarter worth about $11,179,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.